Literature DB >> 8600468

Use of cis- and trans-ribozymes to remove 5' and 3' heterogeneities from milligrams of in vitro transcribed RNA.

A R Ferré-D'Amaré1, J A Doudna.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8600468      PMCID: PMC145725          DOI: 10.1093/nar/24.5.977

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  5 in total

1.  Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies.

Authors:  S R Price; N Ito; C Oubridge; J M Avis; K Nagai
Journal:  J Mol Biol       Date:  1995-06-02       Impact factor: 5.469

2.  Abortive products as initiating nucleotides during transcription by T7 RNA polymerase.

Authors:  S E Moroney; J A Piccirilli
Journal:  Biochemistry       Date:  1991-10-22       Impact factor: 3.162

3.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

4.  A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.

Authors:  N K Tanner; S Schaff; G Thill; E Petit-Koskas; A M Crain-Denoyelle; E Westhof
Journal:  Curr Biol       Date:  1994-06-01       Impact factor: 10.834

5.  Efficient trans-cleavage of a stem-loop RNA substrate by a ribozyme derived from neurospora VS RNA.

Authors:  H C Guo; R A Collins
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

  5 in total
  69 in total

1.  High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozyme.

Authors:  T P Shields; E Mollova; L Ste Marie; M R Hansen; A Pardi
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Kinetoplastid RNA editing does not require the terminal 3' hydroxyl of guide RNA, but modifications to the guide RNA terminus can inhibit in vitro U insertion.

Authors:  M L Burgess; S Heidmann; K Stuart
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

3.  Investigation of adenosine base ionization in the hairpin ribozyme by nucleotide analog interference mapping.

Authors:  S P Ryder; A K Oyelere; J L Padilla; D Klostermeier; D P Millar; S A Strobel
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

4.  Chemical and enzymatic synthesis of tRNAs for high-throughput crystallization.

Authors:  L D Sherlin; T L Bullock; T A Nissan; J J Perona; F J Lariviere; O C Uhlenbeck; S A Scaringe
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

5.  tRNA-like recognition of group I introns by a tyrosyl-tRNA synthetase.

Authors:  Christopher A Myers; Birte Kuhla; Stephen Cusack; Alan M Lambowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  A trans-acting RNA as a control switch in Escherichia coli: DsrA modulates function by forming alternative structures.

Authors:  R A Lease; M Belfort
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

7.  Superior 5' homogeneity of RNA from ATP-initiated transcription under the T7 phi 2.5 promoter.

Authors:  Tricia M Coleman; Guocan Wang; Faqing Huang
Journal:  Nucleic Acids Res       Date:  2004-01-15       Impact factor: 16.971

8.  General plasmids for producing RNA in vitro transcripts with homogeneous ends.

Authors:  Scott C Walker; Johanna M Avis; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

9.  A general method for rapid and nondenaturing purification of RNAs.

Authors:  Jeffrey S Kieft; Robert T Batey
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

10.  Generating in vitro transcripts with homogenous 3' ends using trans-acting antigenomic delta ribozyme.

Authors:  Agnieszka Wichlacz; Michał Legiewicz; Jerzy Ciesiołka
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.